THE USE OF RISPERIDONE, AN ATYPICAL NEUROLEPTIC, IN LEWY BODY DISEASE

被引:33
作者
LEE, H [1 ]
COONEY, JM [1 ]
LAWLOR, BA [1 ]
机构
[1] ST PATRICKS HOSP,DUBLIN 8,IRELAND
关键词
RISPERIDONE; LEWY BODY DEMENTIA; CASE REPORT; EXTRAPYRAMIDAL SIDE-EFFECTS;
D O I
10.1002/gps.930090511
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A case of senile dementia of Lewy body type (SDLBT) who developed severe and incapacitating extrapyramidal side-effects (EPSE) following treatment with typical neuroleptics, but responded to and tolerated the new atypical neuroleptic risperidone, is described. The potential benefits of atypical neuroleptics for elderly dementia patients with concurrent psychotic and behavioural symptoms are discussed.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 12 条
[1]  
Byrne EJ, 1991, DEMENTIA, V2, P283
[2]   A PILOT-STUDY OF HALOPERIDOL TREATMENT OF PSYCHOSIS AND BEHAVIORAL DISTURBANCE IN ALZHEIMERS-DISEASE [J].
DEVANAND, DP ;
SACKEIM, HA ;
BROWN, RP ;
MAYEUX, R .
ARCHIVES OF NEUROLOGY, 1989, 46 (08) :854-857
[3]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[4]   NEUROLEPTIC SENSITIVITY IN PATIENTS WITH SENILE DEMENTIA OF LEWY BODY TYPE [J].
MCKEITH, I ;
FAIRBAIRN, A ;
PERRY, R ;
THOMPSON, P ;
PERRY, E .
BRITISH MEDICAL JOURNAL, 1992, 305 (6855) :673-678
[5]   THERAPEUTIC EFFECT AND SAFETY OF INCREASING DOSES OF RISPERIDONE (R-64766) IN PSYCHOTIC-PATIENTS [J].
MESOTTEN, F ;
SUY, E ;
PIETQUIN, M ;
BURTON, P ;
HEYLEN, S ;
GELDERS, Y .
PSYCHOPHARMACOLOGY, 1989, 99 (04) :445-449
[6]  
*OLD AM RES SERV M, 1968, MULT FUNCT ASS
[7]  
OVERALL JE, 1962, PSYCHOL REP, V10, P799
[8]  
PERRY EK, 1991, ANN NY ACAD SCI, V640, P197
[9]   SENILE DEMENTIA OF LEWY BODY TYPE - A CLINICALLY AND NEUROPATHOLOGICALLY DISTINCT FORM OF LEWY BODY DEMENTIA IN THE ELDERLY [J].
PERRY, RH ;
IRVING, D ;
BLESSED, G ;
FAIRBAIRN, A ;
PERRY, EK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 95 (02) :119-139
[10]  
SEEMAN P, 1980, PHARMACOL REV, V32, P229